Company Valuation: Pasithea Therapeutics Corp.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2024 2025 2026 2027 2028
Market Cap 1 38.74 18.77 3.989 29.79 14.51 - -
Change - -51.55% - 646.69% -51.28% - -
Enterprise Value (EV) -14.22 18.77 3.989 29.79 14.51 14.51 14.51
Change - 231.95% - 646.69% -51.28% 0% 0%
P/E - - -0.25x - - - -
PBR - - - - - - -
PEG - - - - - - -
Capitalization / Revenue 2,573x 38.6x - - - - -
EV / Revenue -0x 0x - - - - -
EV / EBITDA 0x - - -0x -0.55x -0.43x -0.33x
EV / EBIT 0x - - -0x -0.55x -0.43x -0.33x
EV / FCF - - - - - - -
FCF Yield - - - - - - -
Dividend per Share 2 - - - - - - -
Rate of return - - - - - - -
EPS 2 - - -12.69 - - - -
Distribution rate - - - - - - -
Net sales 1 0.0151 0.4866 - - - - -
EBITDA 1 -4.506 - - -20.19 -26.4 -33.8 -44.4
EBIT 1 -4.507 - - -20.86 -26.4 -33.8 -44.4
Net income - - -13.9 - - - -
Net Debt -52.97 - - - - - -
Reference price 2 35.4000 12.8340 3.1500 1.2900 0.4343 0.4343 0.4343
Nbr of stocks (in thousands) 1,094 1,462 1,266 23,091 33,414 - -
Announcement Date 3/30/22 3/30/23 3/24/25 3/30/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 14.51M
17.32x6.64x12.72x1.72% 66.37B
31.83x8.5x28.08x0.07% 58.86B
38.41x6.84x20.46x0.85% 55.22B
44.35x6.2x29.52x-.--% 47.21B
33.62x3.22x13.9x-.--% 42.45B
35.98x8.9x23.21x0.36% 36.44B
-19.28x55.7x-21.11x-.--% 35.19B
41.59x8.02x26.91x-.--% 32.66B
-74.36x14.09x-75.73x-.--% 26.73B
Average 16.61x 13.12x 6.44x 0.33% 40B
Weighted average by Cap. 21.61x 11.64x 11.39x 0.44%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Pasithea Therapeutics Corp.

Historical PBR trend

Valuation ratios - PBR - Pasithea Therapeutics Corp.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Pasithea Therapeutics Corp.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Pasithea Therapeutics Corp.

  1. Stock Market
  2. Stocks
  3. KTTA Stock
  4. Valuation Pasithea Therapeutics Corp.